Building on positive momentum, it’s time to implement centralisation and deliver shorter approval times.
The past year has seen renewed political and industry alignment on how to strengthen Europe’s clinical research ecosystem.
Whisper it: cautious optimism is in the air.
By deepening mutual understanding and highlighting concrete ways to drive innovation, the Accelerating Clinical Trials in the EU (ACT EU), which holds its annual meeting at the European Medicines Agency in Amsterdam this week, is providing a foundation on which to build.
